Multicomponent Breathlessness and Physical Activity Intervention in People With Asthma Using a Digital Platform

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Newcastle, Australia

About this trial

Treating breathlessness could help people with asthma have fewer symptoms and be more physically active. People with asthma report that it is important to deal with breathlessness during physical activity programs, but past research hasn't focused on this need.

The investigators have developed a multicomponent digitally supported intervention targeting breathlessness and physical inactivity. This study will test whether the multicomponent digital supported intervention will help people with asthma. The main question the study aims to answer is:

Does the multicomponent digitally supported intervention improve quality of life?

Participants will:

* Be allocated to the intervention or usual care. Allocation to either group will be random (like tossing a coin). * Attend study visits to complete an assessment involving questionnaires and measurements * Receive telephone calls to ask questions about health * Be invited to take part in an interview to have a conversation about thoughts on participating in the study * Be asked to provide consent to collect information from Services Australia regarding use of health care services and medications

Eligibility criteria

Qualifiers

Aged 18 years or older

Able to provide informed consent

Evidence of variable airflow limitation within the past 10-years to confirm asthma diagnosis

Meets diagnostic criteria for moderate, or severe asthma

Disqualifiers

High dependence on medical care

Significant life-limiting comorbidity (<12 months life expectancy)

Cognitive impairment, poor English language skills or significant untreated hearing impairment that prevents completion of data collection forms or understanding of verbal instructions

Current participation in any other clinical trial, or participation in another clinical trial within the 4-weeks preceding study entry.

Trial design

Treatments tested in this trial

  • Multicomponent digital self-management platform
  • Enhanced usual care

Treatment groups

300 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Newcastle, Australia

Lead sponsor

University of South Australia

Collaborator

The Hong Kong Polytechnic University

Collaborator

University of Sao Paulo

Collaborator

The Thoracic Society of Australia and New Zealand

Collaborator

Asthma Australia

Collaborator

Hunter New England Local Health District

Collaborator